AB
ETNB

Amalgamated Bank’s 89bio ETNB Stock Holding History

Amalgamated Bank’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,857
Closed -$57K – 2978
2025
Q3 		$57K Hold
3,857
– – ﹤0.01% 1806
2025
Q2 		$38K Hold
3,857
– – ﹤0.01% 1908
2025
Q1 		$28K Buy
3,857
+1,188
+45% +$10.4K ﹤0.01% 1953
2024
Q4 		$21K Hold
2,669
– – ﹤0.01% 2096
2024
Q3 		$20K Hold
2,669
– – ﹤0.01% 2132
2024
Q2 		$21K Hold
2,669
– – ﹤0.01% 2096
2024
Q1 		$31K Sell
2,669
-6,082
-70% -$67.3K ﹤0.01% 1992
2023
Q4 		$98K Sell
8,751
-620
-7% -$5.7K ﹤0.01% 2002
2023
Q3 		$145K Hold
9,371
– – ﹤0.01% 1888
2023
Q2 		$178K Buy
+9,371
New +$165K ﹤0.01% 1865
2022
Q2 		– Sell
-1,226
Closed -$5K – 3085
2022
Q1 		$5K Buy
+1,226
New +$7.9K ﹤0.01% 3027

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Amalgamated Bank's ETNB Position: Q4 2025 in Review

Amalgamated Bank sold out of 89bio (ETNB) in Q4 2025, closing a stake of 3,857 shares — an estimated $57K sold.

Amalgamated Bank first reported a position in ETNB in Q1 2022 and held it in 11 quarters. The position peaked at $178K in Q2 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Amalgamated Bank reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Amalgamated Bank sold 3,857 89bio shares in Q4 2025, an estimated $57K.
  • Amalgamated Bank first reported a position in 89bio in Q1 2022 and held it in 11 quarters.
  • Amalgamated Bank's 89bio position peaked at $178K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Amalgamated Bank's 13F filing for Q4 2025, filed 5 Feb 2026.